Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Parichehr Shamsrizi"'
Autor:
Jakob Vielhauer, Ujjwal Mukund Mahajan, Kristina Adorjan, Christopher Benesch, Bettina Oehrle, Georg Beyer, Simon Sirtl, Anna-Lena Johlke, Julian Allgeier, Anna Pernpruner, Johanna Erber, Parichehr Shamsrizi, Christian Schulz, Fady Albashiti, Ludwig Christian Hinske, Julia Mayerle, Hans Christian Stubbe
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract Our prototype system designed for clinical data acquisition and recording of studies is a novel electronic data capture (EDC) software for simple and lightweight data capture in clinical research. Existing software tools are either costly or
Externí odkaz:
https://doaj.org/article/b8bfe437254d4bc4813ae7c6e8bf3234
Autor:
Lisa Felgendreff, Felix G. Rebitschek, Mattis Geiger, Parichehr Shamsrizi, Mirjam A. Jenny, Cornelia Betsch
Publikováno v:
European Journal of Health Communication (EJHC), Vol 5, Iss 1 (2024)
Vaccine effectiveness and safety concerns can prevent people from receiving their first Covid-19 vaccines or boosters. Understanding the vaccine mechanism may lead people to perceive vaccine effectiveness appropriately. This study tested whether help
Externí odkaz:
https://doaj.org/article/d9cc47132e81474cbaa4421d4f7af0a0
Autor:
Sarah Eitze, Philipp Sprengholz, Lars Korn, Parichehr Shamsrizi, Lisa Felgendreff, Cornelia Betsch
Publikováno v:
Vaccine: X, Vol 16, Iss , Pp 100417- (2024)
Context: Long COVID can appear as a severe late consequence (sequela) of a COVID-19 infection, leading to the inability to work or participate in social life for an unknown amount of time. To see friends or family struggling with long COVID might inf
Externí odkaz:
https://doaj.org/article/79b0cd7e20c34b998b67ed7c13648f29
Autor:
Thirumalaisamy P. Velavan, Salih Kuk, Le Thi Kieu Linh, Carlos Lamsfus Calle, Albert Lalremruata, Srinivas Reddy Pallerla, Andrea Kreidenweiss, Jana Held, Meral Esen, Julian Gabor, Eva Maria Neurohr, Parichehr Shamsrizi, Anahita Fathi, Erwin Biecker, Christoph P. Berg, Michael Ramharter, Marylyn Martina Addo, Benno Kreuels, Peter G. Kremsner
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
Abstract Early detection of severe forms of COVID-19 is absolutely essential for timely triage of patients. We longitudinally followed-up two well-characterized patient groups, hospitalized moderate to severe (n = 26), and ambulatory mild COVID-19 pa
Externí odkaz:
https://doaj.org/article/e5dce0aa5f814813812fa7a033bb0c68
Publikováno v:
European Journal of Health Communication (EJHC), Vol 3, Iss 2 (2022)
Misinformation and media reports about critical events in vaccine trials challenge public confidence in Covid-19 vaccine safety. Three online experiments using 2×2 between-subjects designs examined the impact of vaccine type, misinformation debunkin
Externí odkaz:
https://doaj.org/article/a4fea0c7ce3941f6a71a626c0a9ebe38
Autor:
Julian J. Gabor, Andrea Kreidenweiss, Stefan Weber, Moaaz Salama, Mihaly Sulyok, Zita Sulyok, Erik Koehne, Meral Esen, Benno Kreuels, Parichehr Shamsrizi, Erwin Biecker, Benjamin Mordmüller, Christoph P. Berg, Stefano Fusco, Carsten Köhler, Stefan Kubicka, Jens Leitlein, Marylyn Addo, Michael Ramharter, Matthias Schwab, Alfred Lennart Bissinger, Thirumalaisamy P. Velavan, Sanjeev Krishna, Peter G. Kremsner
Publikováno v:
International Journal of Infectious Diseases, Vol 106, Iss , Pp 265-268 (2021)
Introduction: Use of hydroxychloroquine in patients with coronavirus disease 2019 (COVID-19) was widespread and uncontrolled until recently. Patients vulnerable to severe COVID-19 are at risk of hydroxychloroquine interactions with co-morbidities and
Externí odkaz:
https://doaj.org/article/9888908ba0d14c638c6132ddedfaa7f5
Publikováno v:
Vaccines, Vol 9, Iss 10, p 1208 (2021)
The development of an effective vaccine against SARS-CoV-2 marks one of the highest priorities during the ongoing pandemic. However, recruitment of participants for clinical trials can be challenging, and recruitment failure is among the most common
Externí odkaz:
https://doaj.org/article/baec7b97a5b94d598b6b67d3472355da
Autor:
Ujjwal Mukund Mahajan, Johanna Erber, Parichehr Shamsrizi, Florian Voit, Jakob Vielhauer, Anna-Lena Johlke, Christopher Benesch, Najib Ben Khaled, Felix Reinecke, Wolf-Stephan Rudi, Matthias Klein, Carolin Jakob, Marcus Oswald, Rainer König, Christian Schulz, Julia Mayerle, Hans Christian Stubbe
Publikováno v:
Infection.
Purpose Identification of patients at risk of complicated or more severe COVID-19 is of pivotal importance, since these patients might require monitoring, antiviral treatment, and hospitalization. In this study, we prospectively evaluated the SACOV-1
Publikováno v:
Vaccines, Vol 9, Iss 3, p 238 (2021)
We are in the midst of a pandemic caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes the coronavirus disease 2019 (COVID-19). SARS-CoV-2 has caused more than two million deaths after one year of the pandemi
Externí odkaz:
https://doaj.org/article/a69cf6336ebf4ad296d4515a2a256c8d